Charles S. Sweet

3.8k total citations
91 papers, 2.5k citations indexed

About

Charles S. Sweet is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Physiology. According to data from OpenAlex, Charles S. Sweet has authored 91 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Cardiology and Cardiovascular Medicine, 29 papers in Molecular Biology and 17 papers in Physiology. Recurrent topics in Charles S. Sweet's work include Blood Pressure and Hypertension Studies (16 papers), Renin-Angiotensin System Studies (15 papers) and Eicosanoids and Hypertension Pharmacology (14 papers). Charles S. Sweet is often cited by papers focused on Blood Pressure and Hypertension Studies (16 papers), Renin-Angiotensin System Studies (15 papers) and Eicosanoids and Hypertension Pharmacology (14 papers). Charles S. Sweet collaborates with scholars based in United States, United Kingdom and Japan. Charles S. Sweet's co-authors include Allan I. Goldberg, Mary C. Dunlay, Alexander Scriabine, Dennis M. Gross, Michael J. Brody, Karen E. Arcuri, Carl T. Ludden, Philip J. Kadowitz, Herbert C. Wenger and Duane Snavely and has published in prestigious journals such as Nature, Science and Endocrinology.

In The Last Decade

Charles S. Sweet

91 papers receiving 2.3k citations

Peers

Charles S. Sweet

CCM

EDM

CMN

PHYSI

Randy L. Webb United States

B. N. C. Prichard United Kingdom

J. Nussberger Switzerland

Doris N. McKinstry United States

Ronald E. Weishaar United States

J. L. McNay United States

Nobuo Sakamoto Japan

Wolfgang Wienen Germany

R.G. Shanks United Kingdom

Edmund J. Sybertz United States

Randy L. Webb United States

Charles S. Sweet

1.8k ×1.2

CCM

1.1k ×1.6

1.1k ×1.5

EDM

240 ×0.8

CMN

583 ×2.5

PHYSI

Citations per year, relative to Charles S. Sweet Charles S. Sweet (= 1×) peers Randy L. Webb

Countries citing papers authored by Charles S. Sweet

Since Specialization

Citations

This map shows the geographic impact of Charles S. Sweet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles S. Sweet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles S. Sweet more than expected).

Fields of papers citing papers by Charles S. Sweet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles S. Sweet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles S. Sweet. The network helps show where Charles S. Sweet may publish in the future.

Co-authorship network of co-authors of Charles S. Sweet

This figure shows the co-authorship network connecting the top 25 collaborators of Charles S. Sweet. A scholar is included among the top collaborators of Charles S. Sweet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles S. Sweet. Charles S. Sweet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Paster, Robert Zorba, et al.. (1998). Use of losartan in the treatment of hypertensive patients with a history of cough induced by angiotensin-converting enzyme inhibitors. Clinical Therapeutics. 20(5). 978–989. 28 indexed citations

Arcuri, Karen E., et al.. (1997). Comparative Antihypertensive Effects of Losartan 50 mg and Losartan 50 mg Titrated to 100 mg in Patients with Essential Hypertension. Blood Pressure. 6(1). 35–43. 48 indexed citations

Byyny, Richard L., Debora Merrill, Thomas E. Bradstreet, & Charles S. Sweet. (1996). An inpatient trial of the safety and efficacy of losartan compared with placebo and enalapril in patients with essential hypertension. Cardiovascular Drugs and Therapy. 10(3). 313–319. 9 indexed citations

Ruilope, Luís M., et al.. (1996). Controlled Trial of Losartan Given Concomitantly with Different Doses of Hydrochlorothiazide in Hypertensive Patients. Blood Pressure. 5(1). 32–40. 64 indexed citations

MacFadyen, Robert J., et al.. (1995). Haemodynamic and Renal Responses to Oral Losartan Potassium During Salt Depletion or Salt Repletion in Normal Human Volunteers. Journal of Cardiovascular Pharmacology. 25(4). 511–517. 27 indexed citations

Goldberg, Allan I., Mary C. Dunlay, & Charles S. Sweet. (1995). Safety and tolerability of losartan potassium, an angiotensin II receptor antagonist, compared with hydrochlorothiazide, atenolol, felodipne ER, and angiotensin-converting enzyme inhibitors for the treatment of systemic hypertension. The American Journal of Cardiology. 75(12). 793–795. 211 indexed citations

Goldberg, Allan I., Mary C. Dunlay, & Charles S. Sweet. (1995). Safety and tolerability of losartan compared with atenolol, felodipine and angiotensin converting enzyme inhibitors. Journal of Hypertension. 13(Supplement 1). S77–S80. 20 indexed citations

Dahlöf, Björn, et al.. (1995). Efficacy and tolerability of losartan potassium and atenolol in patients with mild to moderate essential hypertension*. American Journal of Hypertension. 8(6). 578–583. 76 indexed citations

Mallion, Jean‐Michel, et al.. (1995). Antihypertensive efficacy and tolerability of once daily losartan potassium compared with captopril in patients with mild to moderate essential hypertension. Journal of Hypertension. 13(Supplement 1). S35–S41. 33 indexed citations

10.

Sweet, Charles S. & Ewa Rucinska. (1994). Losartan in Heart Failure: Preclinical Experiences and Initial Clinical Outcomes. European Heart Journal. 15(suppl D). 139–144. 17 indexed citations

11.

Sweet, Charles S., et al.. (1994). Pharmacodynamic Activity of Intravenous E-3174, an Angiotensin II Antagonist, in Patients With Essential Hypertension. American Journal of Hypertension. 7(12). 1035–1040. 51 indexed citations

12.

Sweet, Charles S.. (1990). Issues surrounding a local cardiac renin system and the beneficial actions of angiotensin-converting enzyme inhibitors in Ischemic myocardium. The American Journal of Cardiology. 65(19). 11–13. 8 indexed citations

13.

Sweet, Charles S., Carl T. Ludden, Inez I. Stabilito, Scott E. Emmert, & Joseph F. Heyse. (1988). Beneficial effects of milrinone and enalapril on long-term survival of rats with healed myocardial infarction. European Journal of Pharmacology. 147(1). 29–37. 40 indexed citations

14.

Sweet, Charles S., Scott E. Emmert, Inez I. Stabilito, & Lair G.T. Ribeiro. (1987). Increased Survival in Rats with Congestive Heart Failure Treated with Enalapril. Journal of Cardiovascular Pharmacology. 10(6). 636–642. 55 indexed citations

15.

Sweet, Charles S., Carl T. Ludden, Lair G.T. Ribeiro, et al.. (1985). Hemodynamic effects of synthetic atrial natriuretic factor (ANF) in dogs with acute left ventricular failure. European Journal of Pharmacology. 115(2-3). 267–276. 17 indexed citations

16.

Pettibone, Douglas J., Charles S. Sweet, Edwin A. Risley, & Thomas P. Kennedy. (1985). A structurally novel stimulator of guanylate cyclase with long-lasting hypotensive activity in the dog. European Journal of Pharmacology. 116(3). 307–312. 5 indexed citations

17.

Sweet, Charles S., et al.. (1984). Structure-activity studies with angiotensin converting enzyme inhibitors related to enalapril and MK-521.. 36–46. 1 indexed citations

18.

Baldwin, John J., Ralph Hirschmann, Mark B. Freedman, et al.. (1983). ChemInform Abstract: β1‐SELECTIVE ADRENOCEPTOR ANTAGONISTS: EXAMPLES OF THE 2‐(4‐(3‐(SUBSTITUTED‐AMINO)‐2‐HYDROXYPROPOXY)PHENYL)IMIDAZOLE CLASS. Chemischer Informationsdienst. 14(48). 1 indexed citations

19.

Baldwin, J. J., et al.. (1982). Tyrosine progenitors as anti hypertensive agents. 17(4). 297–300. 2 indexed citations

20.

Kadowitz, Philip J., Charles S. Sweet, & Michael J. Brody. (1971). Differential effects of prostaglandins E 1 , E 2 , F 1 and F 2 on adrenergic vasoconstriction in the dog hindpaw.. PubMed. 177(3). 641–9. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact